Biotech Investors & VC Firms in New York
143 firms in this list, with a median first check of $500K. 31 of them lead rounds. Generated from verified public data and updated continuously.
Altium Capital
New YorkSeed–Growth
7 people
atai Life Sciences
New YorkSeed–Late Stage
16 people
NYBC Ventures
New YorkSeed–Series B
8 people
Amzak Health
New YorkSeed–Late Stage
4 people
Valhalla Ventures
New YorkPre-Seed–Seed$10M
3 people
ExSight Ventures
New YorkPre-Seed–Series B
4 people
Corner Ventures
New YorkSeed–Late Stage
12 people
Deviation Capital
New YorkSeed–Growth
6 people
TO VC
New YorkSeed–Series B
5 people
New Leaf Venture Partners
New YorkSeed–Late Stage
7 people
JSD Capital, LLC
New YorkSeed–Late Stage$10M
8 people
Petri
New YorkPre-Seed$100K – $6M
5 people
Avant Bio
New YorkSeed–Growth
6 people
Allerfund Ventures, Llc
New YorkPre-Seed–Series A
5 people
Earth First Food Ventures
New York
9 people
Arkitekt Ventures
New YorkSeed–Series A$100K – $10M
1 person
ACORN BIOVENTURES
New YorkSeed–Late Stage
3 people
Global Health Investment Corporation
New YorkSeed–Series B
6 people
Alger
New York
4 people
OTV
New YorkSeries C–Late Stage
Companion Fund
New YorkPre-Seed–Growth
Serendipity Impact VC
New YorkPre-Seed–Series B
6 people
NYVC Ventures
New YorkPre-Seed–Series B
5 people
LifeSci Venture Partners
New YorkSeries A–Late Stage
2 people
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Investors & VC Firms in Europe (5528)Crypto & Web3 Investors & VC Firms (4819)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3737)Investors & VC Firms in Asia-Pacific (3575)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.












































































